Business · National
Danes Are Crooning Over Novo Despite Drugmaker’s Share Slump
It’s been a painful couple of years for Denmark’s nearly 700,000-strong army of retail investors in Novo Nordisk A/S as the weight-loss drugmaker has lost market share to US rival Eli Lilly & Co.
Verified Timeline
No verified timeline updates.
What is your view on “Danes Are Crooning Over Novo Despite Drugmaker’s Share Slump”?
This is self-selected reader participation, not representative scientific polling.

